| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 120, 1201-1211, Copyright © 1987 by Endocrine Society
ARTICLES |
BM Chronwall, WR Millington, WS Griffin, JR Unnerstall and TL O'Donohue
The melanotroph, a polyhedral secretory cell with an ovoid smooth nucleus, is the primary cell type of the intermediate lobe (IL) of the rat pituitary. The melanotrophs are not uniform, but differ in the tinctorial properties of their cytoplasm; some cells appear distinctly darker, others lighter, and cells staining in intermediate shades are also found. In addition, in situ hybridization using proopiomelanocortin (POMC) probes shows an uneven distribution of POMC mRNA among melanotrophs, indicating that different cells maintain different levels of biosynthetic activity. Dopaminergic drugs known to alter the secretion of POMC-related peptides from the IL produced parallel changes in histological staining properties and the amount of POMC mRNA per cell, as determined by in situ hybridization. Acute bromocriptine treatment (6 h) produced a dramatic reduction in grain counts over melanotroph cytoplasm (to 10% of the control levels). A similar reduction persisted after chronic treatment. Six hours after a single haloperidol injection, the grain counts were 180% of control levels. After chronic haloperidol treatment, they were further elevated to 300% of control levels. Chronic bromocriptine and haloperidol treatment also changed the thickness of the IL. Bromocriptine reduced and haloperidol treatment increased the number of cell layers in the IL by changing the rate of cell proliferation. Thus, haloperidol treatment significantly increased and bromocriptine treatment significantly decreased the number of melanotrophs labeled by [3H]thymidine. The mitotic index followed the same trend. These results suggest that dopamine regulation of the IL acts by two different mechanisms: POMC gene expression and cellular proliferation. The change in POMC gene expression is the cell's first rapid response. The influence on the cell cycle appears after subchronic and chronic treatment.
This article has been cited by other articles:
![]() |
S.-N. Lee, B. Peng, R. Desjardins, J. E Pintar, R. Day, and I. Lindberg Strain-specific steroidal control of pituitary function J. Endocrinol., March 1, 2007; 192(3): 515 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vazquez-Martinez, J. P. Castano, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, and M. M. Malagon Melanotrope secretory cycle is regulated by physiological inputs via the hypothalamus Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1039 - E1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ben-Jonathan and R. Hnasko Dopamine as a Prolactin (PRL) Inhibitor Endocr. Rev., December 1, 2001; 22(6): 724 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. González de Aguilar, M. M. Malagón, R. M. Vázquez-Martínez, A. J. Martínez-Fuentes, M. C. Tonon, H. Vaudry, and F. Gracia-Navarro Differential Effects of Dopamine on Two Frog Melanotrope Cell Subpopulations Endocrinology, January 1, 1999; 140(1): 159 - 164. [Abstract] [Full Text] |
||||
![]() |
R. Hnasko, S. Khurana, N. Shackleford, R. Steinmetz, M. J. Low, and N. Ben-Jonathan Two Distinct Pituitary Cell Lines from Mouse Intermediate Lobe Tumors: A Cell that Produces Prolactin-Regulating Factor and a Melanotroph Endocrinology, December 1, 1997; 138(12): 5589 - 5596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Gonzalez de Aguilar, M. M. Malagon, R. M. Vazquez-Martinez, I. Lihrmann, M.-C. Tonon, H. Vaudry, and F. Gracia-Navarro Two Frog Melanotrope Cell Subpopulations Exhibiting Distinct Biochemical and Physiological Patterns in Basal Conditions and under Thyrotropin-Releasing Hormone Stimulation Endocrinology, March 1, 1997; 138(3): 970 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
Nikitin AYu and W H Lee Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice. Genes & Dev., August 1, 1996; 10(15): 1870 - 1879. [Abstract] [PDF] |
||||
![]() |
L. Tecott, J. Barchas, and J. Eberwine In situ transcription: specific synthesis of complementary DNA in fixed tissue sections Science, June 17, 1988; 240(4859): 1661 - 1664. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |